Evidence map›Paper›PMID 24371280›Full record

ArticleNucleic acids research2014

The effects of polymorphisms on human gene targeting.

David R Deyle, Li B Li, Gaoying Ren, David W Russell

Abstract read
In one paragraph

Article in Nucleic acids research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  6. Review
  7. Silent IL2RG Gene Editing in Human Pluripotent Stem Cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2016
    Article
  8. Article
  9. Article
  10. Article
  11. Genome editing in human stem cells.Methods in enzymology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David R DeyleDepartment of Medicine, University of Washington, Seattle, WA, 98195, USA and Department of Biochemistry, University of Washington, Seattle, WA, 98195, USA.
Li B Li
Gaoying Ren
David W Russell

Funding

VECTOR CONSTRUCTIONS FOR GENE THERAPY OF SICKLE CELL DISEASEP01HL053750 · NHLBI · UNIVERSITY OF WASHINGTON · PI RIVIERI, ISABELLE · 1994 to 2014
$30.4M
GENE TARGETING BY VIRAL VECTORSR01DK055759 · NIDDK · UNIVERSITY OF WASHINGTON · PI RUSSELL, DAVID W · 1999 to 2017
$5.8M
GENE TARGETING STRATEGIES FOR THE TREATMENT OF OSTEOGENESIS IMPERFECTAR01AR048328 · NIAMS · UNIVERSITY OF WASHINGTON · PI RUSSELL, DAVID W · 2001 to 2010
$4.0M
Gene targeting with AAV vectors for the treatment of Osteogenesis ImperfectaK08AR053917 · NIAMS · UNIVERSITY OF WASHINGTON · PI DEYLE, DAVID R · 2008 to 2012
$658k
NHLBI NIH HHS HL53750NIAMS NIH HHS AR48328NIAMS NIH HHS AR53917NIAMS NIH HHS AR53917-02S1NIAMS NIH HHS K08 AR053917NIDDK NIH HHS DK55759NIDDK NIH HHS R01 DK055759
6 · The paper itself

Abstract

DNA mismatches that occur between vector homology arms and chromosomal target sequences reduce gene targeting frequencies in several species; however, this has not been reported in human cells. Here we demonstrate that even a single mismatched base pair can significantly decrease human gene targeting frequencies. In addition, we show that homology arm polymorphisms can be used to direct allele-specific targeting or to improve unfavorable vector designs that introduce deletions.

Indexed as

Gene TargetingPolymorphism, GeneticBase Pair MismatchCell Line, TumorChromosomesGenetic LociGenetic VectorsHumansPolymorphism, Single Nucleotide

Identifiers

PMID24371280
PMCPMC3950700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.